R01 AI042382/AI/NIAID NIH HHS/United States[Grants and Funding] - Search Results

Year	Number of Results
1999	2
2002	3
2004	2
2005	1
2006	2
2007	1
2008	2
2009	4
2010	2
2024	0

1

A heterospecific leucine zipper tetramer.

Deng Y, Liu J, Zheng Q, Li Q, Kallenbach NR, Lu M. Deng Y, et al. Chem Biol. 2008 Sep 22;15(9):908-19. doi: 10.1016/j.chembiol.2008.07.008. Chem Biol. 2008. PMID: 18804028 Free PMC article.

2

A seven-helix coiled coil.

Liu J, Zheng Q, Deng Y, Cheng CS, Kallenbach NR, Lu M. Liu J, et al. Proc Natl Acad Sci U S A. 2006 Oct 17;103(42):15457-62. doi: 10.1073/pnas.0604871103. Epub 2006 Oct 9. Proc Natl Acad Sci U S A. 2006. PMID: 17030805 Free PMC article.

3

Detailed mechanistic insights into HIV-1 sensitivity to three generations of fusion inhibitors.

Eggink D, Langedijk JP, Bonvin AM, Deng Y, Lu M, Berkhout B, Sanders RW. Eggink D, et al. J Biol Chem. 2009 Sep 25;284(39):26941-50. doi: 10.1074/jbc.M109.004416. Epub 2009 Jul 17. J Biol Chem. 2009. PMID: 19617355 Free PMC article.

4

Helix formation and the unfolded state of a 52-residue helical protein.

Cao W, Bracken C, Kallenbach NR, Lu M. Cao W, et al. Protein Sci. 2004 Jan;13(1):177-89. doi: 10.1110/ps.03383004. Protein Sci. 2004. PMID: 14691233 Free PMC article.

5

Structural and biological mimicry of protein surface recognition by alpha/beta-peptide foldamers.

Horne WS, Johnson LM, Ketas TJ, Klasse PJ, Lu M, Moore JP, Gellman SH. Horne WS, et al. Proc Natl Acad Sci U S A. 2009 Sep 1;106(35):14751-6. doi: 10.1073/pnas.0902663106. Epub 2009 Aug 17. Proc Natl Acad Sci U S A. 2009. PMID: 19706443 Free PMC article.

6

Stabilization of the soluble, cleaved, trimeric form of the envelope glycoprotein complex of human immunodeficiency virus type 1.

Sanders RW, Vesanen M, Schuelke N, Master A, Schiffner L, Kalyanaraman R, Paluch M, Berkhout B, Maddon PJ, Olson WC, Lu M, Moore JP. Sanders RW, et al. J Virol. 2002 Sep;76(17):8875-89. doi: 10.1128/jvi.76.17.8875-8889.2002. J Virol. 2002. PMID: 12163607 Free PMC article.

7

Emergence of a drug-dependent human immunodeficiency virus type 1 variant during therapy with the T20 fusion inhibitor.

Baldwin CE, Sanders RW, Deng Y, Jurriaans S, Lange JM, Lu M, Berkhout B. Baldwin CE, et al. J Virol. 2004 Nov;78(22):12428-37. doi: 10.1128/JVI.78.22.12428-12437.2004. J Virol. 2004. PMID: 15507629 Free PMC article.

8

An antibody directed against the fusion peptide of Junin virus envelope glycoprotein GPC inhibits pH-induced membrane fusion.

York J, Berry JD, Ströher U, Li Q, Feldmann H, Lu M, Trahey M, Nunberg JH. York J, et al. J Virol. 2010 Jun;84(12):6119-29. doi: 10.1128/JVI.02700-09. Epub 2010 Apr 14. J Virol. 2010. PMID: 20392854 Free PMC article.

9

Inhibition of human immunodeficiency virus type 1 infectivity by the gp41 core: role of a conserved hydrophobic cavity in membrane fusion.

Ji H, Shu W, Burling FT, Jiang S, Lu M. Ji H, et al. J Virol. 1999 Oct;73(10):8578-86. doi: 10.1128/JVI.73.10.8578-8586.1999. J Virol. 1999. PMID: 10482611 Free PMC article.

10

Subdomain folding and biological activity of the core structure from human immunodeficiency virus type 1 gp41: implications for viral membrane fusion.

Lu M, Ji H, Shen S. Lu M, et al. J Virol. 1999 May;73(5):4433-8. doi: 10.1128/JVI.73.5.4433-4438.1999. J Virol. 1999. PMID: 10196341 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

18 results

Results by year

Search Page

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

18 results

Results by year